What does CUSIP 53566P109 represent in this 13F holders report?

CUSIP 53566P109 is the security identifier for LCTX - Lineage Cell Therapeutics, Inc. - Common shares used to aggregate holder disclosures.

How many institutions held LCTX - Lineage Cell Therapeutics, Inc. - Common shares in Q2 2022?

84 institutional investors reported LCTX - Lineage Cell Therapeutics, Inc. - Common shares for Q2 2022. Use the holders table for investor-level position and value details.

Lineage Cell Therapeutics, Inc. - Common shares (LCTX)

CUSIP: 53566P109

Q2 2022 13F Holders as of 30 Jun 2022

Type / Class: Equity / Common shares
Shares outstanding: 250,425,788
Total 13F shares: 64,980,785
Share change: -7,799,480
Total reported value: $102,682,821
Put/Call ratio: 6.7%
Price per share: $1.58
Number of holders: 84
Value change: -$12,116,491
Number of buys: 30
Number of sells: 51

Quarterly Holders Quick Answers

What is CUSIP 53566P109?
CUSIP 53566P109 identifies LCTX - Lineage Cell Therapeutics, Inc. - Common shares in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2022
Previous quarter: Q1 2022

Recent filing periods for CUSIP 53566P109:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of LCTX - Lineage Cell Therapeutics, Inc. - Common shares (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
BROADWOOD CAPITAL INC	13F	Company	14%	34,935,485	$53,801,000	—	31 Mar 2022	13F
BlackRock Finance, Inc.	13F	Company	3.9%	9,809,122	$15,106,000	—	31 Mar 2022	13F
VANGUARD GROUP INC	13F	Company	2.4%	5,956,931	$9,173,000	—	31 Mar 2022	13F
Defender Capital, LLC.	13F	Company	2%	5,006,185	$7,983,000	—	31 Mar 2022	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.91%	2,275,973	$3,504,000	—	31 Mar 2022	13F
STATE STREET CORP	13F	Company	0.84%	2,105,107	$3,242,000	—	31 Mar 2022	13F
Prescott General Partners LLC	13F	Company	0.74%	1,851,851	$2,852,000	—	31 Mar 2022	13F
JPMORGAN CHASE & CO	13F	Company	0.74%	1,849,662	$2,849,000	—	31 Mar 2022	13F
RAFFLES ASSOCIATES LP	13F	Company	0.52%	1,306,095	$2,011,000	—	31 Mar 2022	13F
NORTHERN TRUST CORP	13F	Company	0.41%	1,030,809	$1,587,000	—	31 Mar 2022	13F
TWO SIGMA ADVISERS, LP	13F	Company	0.25%	615,766	$948,000	—	31 Mar 2022	13F
Nuveen Asset Management, LLC	13F	Company	0.22%	551,993	$750,000	—	31 Mar 2022	13F
Bank of New York Mellon Corp	13F	Company	0.16%	410,853	$633,000	—	31 Mar 2022	13F
Deutsche Girozentrale DekaBank	13F	Individual	0.16%	402,100	$607,000	—	31 Mar 2022	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.13%	332,406	$512,000	—	31 Mar 2022	13F
STRS OHIO	13F	Company	0.11%	282,700	$435,000	—	31 Mar 2022	13F
MORGAN STANLEY	13F	Company	0.1%	243,955	$376,000	—	31 Mar 2022	13F
Long Focus Capital Management, LLC	13F	Company	0.09%	215,000	$331,000	—	31 Mar 2022	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.08%	202,996	$312,000	—	31 Mar 2022	13F
LINCOLN NATIONAL CORP	13F	Company	0.08%	192,900	$297,000	—	31 Mar 2022	13F
ETF MANAGERS GROUP, LLC	13F	Company	0.08%	192,627	$289,000	—	31 Mar 2022	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.07%	178,493	$275,000	—	31 Mar 2022	13F
Allspring Global Investments Holdings, LLC	13F	Company	0.07%	170,379	$262,000	—	31 Mar 2022	13F
LPL Financial LLC	13F	Company	0.06%	156,830	$242,000	—	31 Mar 2022	13F
DAFNA Capital Management LLC	13F	Company	0.06%	140,000	$216,000	—	31 Mar 2022	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	0.05%	128,683	$198,000	—	31 Mar 2022	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.05%	127,432	$196,000	—	31 Mar 2022	13F
JANE STREET GROUP, LLC	13F	Company	0.05%	124,210	$191,000	—	31 Mar 2022	13F
Phoenix Financial Ltd.	13F	Company	0.04%	111,545	$172,000	—	31 Mar 2022	13F
RHUMBLINE ADVISERS	13F	Company	0.04%	101,742	$157,000	—	31 Mar 2022	13F
Williams Jones Wealth Management, LLC.	13F	Company	0.04%	101,300	$156,000	—	31 Mar 2022	13F
Aristides Capital LLC	13F	Company	0.04%	100,000	$154,000	—	31 Mar 2022	13F
Fort Sheridan Advisors LLC	13F	Company	0.03%	75,931	$117,000	—	31 Mar 2022	13F
GSA CAPITAL PARTNERS LLP	13F	Company	0.03%	72,506	$112,000	—	31 Mar 2022	13F
NEW YORK STATE COMMON RETIREMENT FUND	13F	Company	0.03%	69,129	$106,000	—	31 Mar 2022	13F
DEUTSCHE BANK AG\	13F	Company	0.03%	68,085	$105,000	—	31 Mar 2022	13F
Strategic Wealth Investment Group, LLC	13F	Company	0.02%	62,488	$96,000	—	31 Mar 2022	13F
AMERICAN INTERNATIONAL GROUP, INC.	13F	Company	0.02%	62,265	$96,000	—	31 Mar 2022	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	0.02%	61,091	$94,000	—	31 Mar 2022	13F
MANUFACTURERS LIFE INSURANCE COMPANY, THE	13F	Company	0.02%	59,658	$91,873	—	31 Mar 2022	13F
CITADEL ADVISORS LLC	13F	Company	0.02%	56,003	$86,000	—	31 Mar 2022	13F
D. E. Shaw & Co., Inc.	13F	Company	0.02%	55,471	$85,000	—	31 Mar 2022	13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	13F	Company	0.02%	53,656	$83,000	—	31 Mar 2022	13F
DCF Advisers, LLC	13F	Company	0.02%	53,000	$82,000	—	31 Mar 2022	13F
VOYA INVESTMENT MANAGEMENT LLC	13F	Company	0.02%	47,315	$73,000	—	31 Mar 2022	13F
COMMONWEALTH EQUITY SERVICES, LLC	13F	Company	0.02%	45,489	$70,000	—	31 Mar 2022	13F
PRINCIPAL FINANCIAL GROUP INC	13F	Company	0.02%	45,159	$70,000	—	31 Mar 2022	13F
Beirne Wealth Consulting Services, LLC	13F	Company	0.02%	45,000	$70,000	—	31 Mar 2022	13F
American Portfolios Advisors	13F	Company	0.02%	44,939	$69,206	—	31 Mar 2022	13F
Invesco Ltd.	13F	Company	0.01%	34,518	$53,000	—	31 Mar 2022	13F

Institutional Holders of Lineage Cell Therapeutics, Inc. - Common shares (LCTX) as of Q2 2022

As of 30 Jun 2022, Lineage Cell Therapeutics, Inc. - Common shares (LCTX) was held by 84 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 64,980,785 shares. The largest 10 holders included BROADWOOD CAPITAL INC, VANGUARD GROUP INC, Defender Capital, LLC., BlackRock Inc., Laurion Capital Management LP, RAFFLES ASSOCIATES LP, Prescott General Partners LLC, JPMORGAN CHASE & CO, GEODE CAPITAL MANAGEMENT, LLC, and MILLENNIUM MANAGEMENT LLC. This page lists 84 institutional shareholders reporting positions in this security for the Q2 2022 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2022 vs Q1 2022 Across Filers

Q1 2022 holders

Q2 2022 holders

Holder diff

-15

Investor	Q1 2022 Shares	Q2 2022 Shares	Share Diff	Share Chg %	Q1 2022 Value $	Q2 2022 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.